BDBM50138935 3-Benzo[1,3]dioxol-5-yl-9-oxo-1,3,4,9-tetrahydro-pyrrolo[3,4-b]quinoline-2-carboxylic acid benzylamide::CHEMBL161408
SMILES: Oc1c2CN(C(c2nc2ccccc12)c1ccc2OCOc2c1)C(=O)NCc1ccccc1
InChI Key: InChIKey=DEEZRURXLJCASJ-UHFFFAOYSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cGMP-specific 3',5'-cyclic phosphodiesterase (Homo sapiens (Human)) | BDBM50138935 (3-Benzo[1,3]dioxol-5-yl-9-oxo-1,3,4,9-tetrahydro-p...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | 1.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson and Johnson Pharmaceutical Research and Development LLC Curated by ChEMBL | Assay Description Inhibitory activity against human Phosphodiesterase 5 | J Med Chem 47: 656-62 (2004) Article DOI: 10.1021/jm020521s BindingDB Entry DOI: 10.7270/Q228070W | |||||||||||
More data for this Ligand-Target Pair |